ID
44999
Description
Principal Investigator: Richard Gilbertson, St. Jude Children's Research Hospital, Memphis, TN, USA MeSH: Medulloblastoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000409 Medulloblastoma is a heterogenous disease made up of at least four distinct subtypes of disease which appear to exploit and disrupt naturally occurring developmental pathways of cellular growth and hindbrain development. To better understand the driver mutations of this disease, we performed whole genome sequencing of 37 medulloblastomas and the corresponding normal DNA of the 37 affected children treated at St. Jude Children's Research Hospital. We have found several novel mutations which appear subtype specific. These mutations were checked for frequency in a separate tumor cohort of 56 children with medulloblastoma, also treated on the St. Jude Medulloblastoma 2003 trial, and were tested in several animal models of medulloblastoma for proof of oncogenic potential.
Lien
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000409
Mots-clés
Versions (2)
- 01/07/2022 01/07/2022 - Dr. Christian Niklas
- 12/10/2022 12/10/2022 - Adrian Schulz
Détendeur de droits
Richard Gilbertson, St. Jude Children's Research Hospital, Memphis, TN, USA
Téléchargé le
1 juillet 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000409 Sequencing of Medulloblastoma
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Subject ID, gender, age at diagnosis, ethnicity, sample description, patient relapse, if patient received bone marrow transplant, genetic lesions, primary protocol of treatment, and disease code of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, analyte type, tumor status, body site where sample was collected, primary tumor location, and histological type of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID and GEO accession ID of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, subject ID, sample source, sample source ID, and sample use variables obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Subject ID, gender, age at diagnosis, ethnicity, sample description, patient relapse, if patient received bone marrow transplant, genetic lesions, primary protocol of treatment, and disease code of participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID, analyte type, tumor status, body site where sample was collected, primary tumor location, and histological type of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
- Sample ID and GEO accession ID of samples obtained from participants with medulloblastoma and involved in the "The Genomic Analysis of Medulloblastoma" project.
C0025149 (UMLS CUI [1,2])
C0332142 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C3640076 (UMLS CUI [2,2])
C0027651 (UMLS CUI [2,3])
C1512693 (UMLS CUI [3,1])
C3640076 (UMLS CUI [3,2])
C0332441 (UMLS CUI [3,3])
C1512693 (UMLS CUI [4,1])
C0021430 (UMLS CUI [4,2])
C2827447 (UMLS CUI [4,3])
C1512693 (UMLS CUI [5,1])
C1547867 (UMLS CUI [5,2])
C1328887 (UMLS CUI [5,3])